A case of COVID-19 diagnosed with favipiravir-induced drug fever based on a positive drug-induced lymphocyte stimulation test-Reference-Cited by-同舟云学术

A case of COVID-19 diagnosed with favipiravir-induced drug fever based on a positive drug-induced lymphocyte stimulation test

Published:2021-05 Issue: Volume:106 Page:33-35
ISSN:1201-9712
Container-title:International Journal of Infectious Diseases
language:en
Short-container-title:International Journal of Infectious Diseases

Author:

Murai Yushi,Kawasuji Hitoshi,Takegoshi Yusuke,Kaneda Makito,Kimoto Kou,Ueno Akitoshi,Miyajima Yuki,Kawago Koyomi,Fukui Yasutaka,Ogami Chika,Sakamaki Ippei,Tsuji Yasuhiro,Morinaga Yoshitomo,Yamamoto Yoshihiro

Funder

Japan Agency for Medical Research and Development

Japan Society for the Promotion of Science

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference17 articles.

1. Remdesivir for the treatment of Covid-19 – final report;Beigel;N Engl J Med,2020

2. Positive direct antiglobulin test in post-artesunate delayed haemolysis: more than a coincidence?;Camprubí;Malar J,2019

3. Tolerability of Favipiravir therapy in critically-ill patients with COVID-19: a report of 4 cases;Dauby;J Med Virol,2021

4. Dexamethasone in hospitalized patients with Covid-19;Horby;N Engl J Med,2021

5. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China;Huang;The Lancet,2020

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of toxicological effects of favipiravir (T‐705) on the lung tissue of rats: An experimental study;Journal of Biochemical and Molecular Toxicology;2023-11-09

2. Histology and cytokine levels in hepatic injury accompanying a case of non-severe COVID-19;Clinical Journal of Gastroenterology;2023-01-24

3. Drug fever: a narrative review;Annals of Clinical Epidemiology;2023

4. Effects of Vitamin C on the Oral-Nasal Mucosal Damage Caused by Favipiravir in Old and Young Rats;Cureus;2022-09-05

5. Therapeutic Status of Famotidine in COVID-19 Patients: A Review;Infectious Disorders - Drug Targets;2022-05